Comparative Study of Rinsulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (GEROPHARM LLC, Russia) and Humulin® NPH, Suspension for Subcutaneous Administration, 100 IU/ml (Lilly France, France) Using the Euglycemic Hyperinsulinemic Clamp Method

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 23, 2017

Primary Completion Date

January 1, 2018

Study Completion Date

May 21, 2018

Conditions

PharmacokineticsBioequivalence

Interventions

DRUG

Rinsulin NPH

subcutaneous injection at a dose of 0.4 IU/kg

DRUG

Humulin NPH

subcutaneous injection at a dose of 0.4 IU/kg

Trial Locations (1)

Yarosslavl Clinical Hospital #3, Yaroslavl